Skip to Content

Vivaglobin Approval History

  • FDA approved: Yes (First approved January 9th, 2006)
  • Brand name: Vivaglobin
  • Generic name: immune globulin subcutaneous (human)
  • Company: ZLB Behring
  • Treatment for: Primary Immunodeficiency Syndrome

Vivaglobin is a pasteurized, polyvalent human normal immunoglobulin for subcutaneous infusion indicated for the treatment of patients with primary immune deficiency (PID).

Development History and FDA Approval Process for Vivaglobin

DateArticle
Jan  9, 2006Approval Vivaglobin Approved - ZLB Behring - Treatment for Primary Immunodeficiencies

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide